Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP8 | P22894 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11878349 | 0.89 | MMP8 (0.31) | MMP8 | |
| SCHEMBL20609969 | 0.83 | LMNA (0.30) | — | |
| SCHEMBL6150877 | 0.81 | OPRM1 (0.33) | — | |
| SCHEMBL28214778 | 0.79 | TSHR (0.38) | — | |
| SCHEMBL5964919 | 0.79 | TSHR (0.38) | — | |
| SCHEMBL21925338 | 0.78 | — | — | |
| SCHEMBL20609956 | 0.78 | — | — | |
| SCHEMBL1659023 | 0.78 | TSHR (0.38) | — | |
| SCHEMBL1007621 | 0.78 | — | — | |
| SCHEMBL24520785 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 332 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2829555-B1 | METHOD FOR PRODUCING OLEFIN POLYMER | MITSUI CHEMICALS INC (JP) | 2018-05-16 | — | — | EP | claimed |
| US-9315602-B2 | Method for producing olefin polymer | MITSUI CHEMICALS, INC. (JP) | 2016-04-19 | — | — | US | claimed |
| US-20100298328-A1 | 1-Heterocyclylamino-2-Hydroxy-3-Amino-Omega-Arylalkanes | VITAE PHARMACEUTICALS, INC | 2010-11-25 | — | — | US | claimed |
| WO-2007123718-A1 | 1-HETEROCYCLYLAMINO-2-HYDROXY-3-AMINO-ω-ARYLALKANES | VITAE PHARMACEUTICALS, INC. (US) | 2007-11-01 | — | — | WO | claimed |
| US-12616728-B2 | Processes and systems for converting cannabinoids into cannabinoid derivatives and isolating the same | SUPER CRITICAL IP, LLC (US) | 2026-05-05 | — | — | US | disclosed |
| US-20260041617-A1 | COSMETIC COMPOSITION APPLICABLE TO THE SKIN AND BASED ON A VOLATILE MIXTURE OF ALKANES | BIOSYNTHIS (FR) | 2026-02-12 | — | — | US | disclosed |
| US-20250177263-A1 | LIPSTICK COMPOSITION BASED ON A VOLATILE MIXTURE OF ALKANES | BIOSYNTHIS (FR) | 2025-06-05 | — | — | US | disclosed |
| US-20250170037-A1 | EYE MAKEUP COMPOSITION BASED ON A VOLATILE MIXTURE OF ALKANES | BIOSYNTHIS (FR) | 2025-05-29 | — | — | US | disclosed |
| US-20250152646-A1 | SOLVENTS, METHODS, AND SYSTEMS FOR ISOLATING CANNABINOIDS FROM PLANTS EXTRACTS OR FROM SYNTHETIC PATHWAYS | NOEL ARMAND J (US) | 2025-05-15 | — | — | US | disclosed |
| EP-4496553-A1 | COSMETIC COMPOSITION APPLICABLE TO THE SKIN AND BASED ON A VOLATILE MIXTURE OF ALKANES | Biosynthis (FR) | 2025-01-29 | — | — | EP | disclosed |
| EP-4486287-A1 | LIPSTICK COMPOSITION BASED ON A VOLATILE MIXTURE OF ALKANES | Biosynthis (FR) | 2025-01-08 | — | — | EP | disclosed |
| EP-4486288-A1 | EYE MAKEUP COMPOSITION BASED ON A VOLATILE MIXTURE OF ALKANES | Biosynthis (FR) | 2025-01-08 | — | — | EP | disclosed |
| EP-0232776-A2 | 2,5,6,7-tetranor-4,8-inter-m-phenylene PGI2 derivatives | TORAY INDUSTRIES, INC. (JP) | 1987-08-19 | — | — | EP | disclosed |
| EP-0224442-A1 | Use of substituted phenols as stabilizers | CIBA-GEIGY AG (CH) | 1987-06-03 | — | — | EP | disclosed |
| EP-0170624-A2 | 2,4,6-Trifunctionalized phenols | CIBA-GEIGY AG (CH) | 1986-02-05 | — | — | EP | disclosed |
| EP-0165209-A2 | o,p-Bifunctionalised, o'-substituted phenols | CIBA-GEIGY AG (CH) | 1985-12-18 | — | — | EP | disclosed |
| EP-0152097-A2 | Stabilized compositions of rigid PVC | CIBA-GEIGY AG (CH) | 1985-08-21 | — | — | EP | disclosed |
| US-4500662-A | STABILIZERS OF POLYMERIC MATERIALS AGAINST ULTRAVIOLET DEGRADATION | THE B. F. GOODRICH COMPANY (US) | 1985-02-19 | — | — | US | disclosed |
| US-4473694-A | Process for the preparation of polysubstituted α-aminoacetamides | THE B. F. GOODRICH COMPANY (US) | 1984-09-25 | — | — | US | disclosed |
| EP-0006992-A1 | 3-(p-Isopropyl-phenyl)-2-methyl-n-propyl amines, fungicides containing these compounds, a method for the preparation of said compounds and a method for combating fungi by using said compounds | BASF Aktiengesellschaft (DE) | 1980-01-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12616728-B2 | Processes and systems for converting cannabinoids into cannabinoid derivatives and isolating the same | CNR2, CNR1, SCD | MMP8 3141/4885 |
| US-20100298328-A1 | 1-Heterocyclylamino-2-Hydroxy-3-Amino-Omega-Arylalkanes | REN, AGTR1, AGTR2 | MMP8 917/4885 |
| US-20260041617-A1 | COSMETIC COMPOSITION APPLICABLE TO THE SKIN AND BASED ON A VOLATILE MIXTURE OF ALKANES | CUTA, AP2M1, LBR | MMP8 2215/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.